p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial

- Sonnenblick, Amir, Salgado, Roberto, Crown, John, Viale, Giuseppe, Daly, Laura, Javdan, Bahar, Fujisawa, Sho, de Azambuja, Evandro, Lieveke, Ameye, Piccart, Martine, Bromberg, Jacqueline, Sotirou, Christos, Brohee, Sylvain, Zahavi, Tamar, Peretz, Tamar, van den Eynden, Gert, Rouas, Ghizlaine, Salmon, Asher, Francis, Prudence A., Di Leo, Angelo

p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial

- Sonnenblick, Amir, Salgado, Roberto, Crown, John, Viale, Giuseppe, Daly, Laura, Javdan, Bahar, Fujisawa, Sho, de Azambuja, Evandro, Lieveke, Ameye, Piccart, Martine, Bromberg, Jacqueline, Sotirou, Christos, Brohee, Sylvain, Zahavi, Tamar, Peretz, Tamar, van den Eynden, Gert, Rouas, Ghizlaine, Salmon, Asher, Francis, Prudence A., Di Leo, Angelo

Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

- Sonnenblick, Amir, Francis, Prudence A., Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Barnadas, Agusti, Cortes-Funes, Hernan, Piccart, Martine, Crown, John, Azim Jr, Hatem A., de Azambuja, Evandro, Nordenskjold, Bo, Gutierez, Jorge, Quinaux, Emmanuel, Mastropasqua, Mauro G., Ameye, Lieveke, Anderson, Michael